Is Everolimus covered by medical insurance? Analysis of medical insurance policy and reimbursement process

Everolimus (Everolimus) has been launched in China and has been included in the scope of medical insurance, providing patients with certain financial support. The drug is mainly used to treat organ transplant rejection, renal cell carcinoma, breast cancer and some neuroendocrine tumors. After being included in medical insurance, patients can pay part of the drug cost through medical insurance and reduce the financial burden of long-term treatment if they meet the relevant reimbursement conditions. Common domestic specifications include 2.5mg 30 tablets and 5mg 30 tablets. The prices are about 2,000 yuan and three to four thousand yuan respectively. The specific prices may vary slightly according to the actual procurement situation of the hospital pharmacy.

In terms of medical insurance reimbursement policy, everolimus is a drug on the medical insurance list, and patients need to purchase it at designated hospitals and settle the bill with a valid medical insurance card. Reimbursement ratios and minimum payment standards vary from region to region. Generally, basic medical insurance can cover part of the cost, and the remaining out-of-pocket portion is borne by the patient. For patients with long-term maintenance treatment or organ transplantation, doctors usually formulate a rational medication plan based on the course of treatment and dosage, and guide patient reimbursement in conjunction with medical insurance policies to ensure continuity and accessibility of treatment.

The reimbursement process is relatively simple: first, the patient needs to use the medical insurance card to purchase everolimus at the hospital's designated pharmacy; second, the pharmacy settlement system will automatically calculate the reimbursable amount based on the medical insurance catalog; then, the patient pays the self-pay part, and the medical insurance part is directly reimbursed by the system. For special diseases or exceeding the standard dosage, some regions can also apply for special approval to increase reimbursement coverage and reduce the burden on patients.

In addition, there are a variety of imitation versions available in overseas markets. The price of Laos Lucius version 5mg30 tablets is 8900 yuan, 10mg30 tablets is about 1,700 yuan; printed The price of 5mg10 tablets is about 700 to 800 yuan, and 10mg10 tablets are around 1,200 to 1,800 yuan. Compared with domestic original drugs, the prices of these generic drugs are more economical, but attention must be paid to the formality of the channels and the quality of the drugs to ensure safe and effective treatment.

Reference materials:https://www.drugs.com/